14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.95 $2.61 Tuesday, 23rd Apr 2024 CHRS stock ended at $2.18. During the day the stock fluctuated 6.90% from a day low at $2.10 to a day high of $2.25.
90 days $1.93 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Jan 04, 2024 $3.05 $3.16 $2.83 $2.92 6 876 823
Jan 03, 2024 $3.10 $3.22 $2.93 $3.02 8 770 121
Jan 02, 2024 $3.33 $3.70 $3.14 $3.14 16 107 122
Dec 29, 2023 $3.31 $3.41 $3.14 $3.33 14 509 606
Dec 28, 2023 $2.65 $3.33 $2.57 $3.24 25 523 026
Dec 27, 2023 $3.00 $3.04 $2.56 $2.69 52 172 830
Dec 26, 2023 $2.05 $2.23 $2.04 $2.18 5 136 271
Dec 22, 2023 $2.05 $2.11 $1.99 $2.02 3 071 883
Dec 21, 2023 $2.03 $2.06 $1.95 $2.02 1 761 921
Dec 20, 2023 $2.14 $2.17 $1.93 $1.94 2 798 950
Dec 19, 2023 $2.05 $2.17 $2.03 $2.12 3 019 871
Dec 18, 2023 $2.20 $2.20 $2.01 $2.03 3 083 551
Dec 15, 2023 $2.30 $2.38 $2.13 $2.17 15 546 289
Dec 14, 2023 $2.40 $2.49 $2.27 $2.30 5 053 428
Dec 13, 2023 $2.10 $2.37 $2.03 $2.37 3 987 792
Dec 12, 2023 $2.13 $2.13 $1.97 $2.09 3 544 398
Dec 11, 2023 $2.23 $2.23 $2.08 $2.11 2 023 463
Dec 08, 2023 $2.16 $2.30 $2.06 $2.22 2 702 545
Dec 07, 2023 $2.30 $2.40 $2.28 $2.30 2 060 875
Dec 06, 2023 $2.21 $2.38 $2.19 $2.29 2 358 305
Dec 05, 2023 $2.25 $2.37 $2.19 $2.20 2 816 510
Dec 04, 2023 $2.34 $2.37 $2.21 $2.30 2 837 889
Dec 01, 2023 $2.13 $2.30 $2.02 $2.30 3 037 435
Nov 30, 2023 $2.30 $2.49 $2.12 $2.13 4 076 433
Nov 29, 2023 $2.15 $2.34 $2.13 $2.18 3 724 946
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT